PRESS RELEASE: IVI Releases Public Comments on Non-Small Cell Lung Cancer Value Tool

2019-07-18T13:08:44-06:00July 18th, 2019|IVI News, Press|

Thank you for your comments!

IVI has released all public feedback received during the open comment period for the IVI-NSCLC model – our open-source platform to assess therapy sequences for EGFR+ non-small cell lung cancer. In the spirit of IVI’s mission of collaboration, commitment to transparency, and dedication to iterative improvement, we look forward to the Technical Expert Panel review.

Read the full press release here.